Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?

Lancet. 2003 Sep 6;362(9386):755-7. doi: 10.1016/S0140-6736(03)14295-X.
No abstract available

Publication types

  • Comment
  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Coronary Disease / drug therapy*
  • Coronary Disease / mortality
  • Follow-Up Studies
  • Humans
  • Myocardial Infarction / prevention & control
  • Perindopril / therapeutic use*
  • Ramipril / therapeutic use*
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Research Design
  • Stroke / prevention & control
  • Treatment Outcome

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Ramipril
  • Perindopril